dr. mcbride on the emergence of biosimilars in oncology
Published 4 years ago • 61 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
1:35
dr. mcbride on the potential of biosimilars in oncology
-
1:30
dr. mcbride on the potential impact of bevacizumab biosimilars in oncology
-
5:59
dr ali mcbride discusses the role of biosimilars in oncology
-
1:11
dr. mcbride on the regulatory pathway for biosimilars in oncology
-
1:27
dr. mcbride on biosimilar rituximab
-
1:48
dr. markman on the concept of biosimilars in oncology
-
7:22
an overview of biosimilarity
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
7:57
biosimilar characterization
-
2:08
biologics and biosimilars basics: what are biosimilars?
-
3:33
biosimilars: manufacturing and inherent variation
-
0:57
dr. somer on the expansion of biosimilars in oncology
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
11:00
examining the economic impacts of biosimilars in oncology
-
0:53
dr. schmid on evaluating biosimilars in oncology
-
0:19
copy of dr. ali on incorporating biosimilars into cancer treatment
-
1:00
dr. kris on the impact of bevacizumab biosimilars in lung cancer
-
0:42
dr. cristofanilli on the need for biosimilars in oncology
-
0:54
dr. kwa on the potential impact of biosimilars in oncology
-
1:00
dr. slamon on the use of trastuzumab and bevacizumab biosimilars in breast cancer
-
0:52
dr. offin on potential implications of introducing biosimilars into oncology
-
1:08
dr. tripathy on the progression of biosimilars in oncology